Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Gordian Biotechnology Inc. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is situated in 1 distinct art unit, which indicates a focused technical scope for the company's current patenting activities. The presence of only a single active matter suggests a targeted strategy for developing its intellectual property portfolio in this highly regulated sector.
The portfolio's prosecution is handled by 1 distinct examiner, BOESEN, CHRISTIAN C, who is the busiest examiner with 1 pending action. This means that the company's current success in the patent office depends on the review and feedback of this single individual. Such a concentrated workload allows the applicant to tailor their responses specifically to the examiner's cited prior art and technical objections.
Because the busiest examiner pending count of 1 matches the total pending office actions, the prosecution process is currently streamlined. In the Biotechnology & Pharmaceuticals field, where technical details are paramount, this centralization can simplify the path to allowance if the examiner's concerns are met. Practitioners should focus on the specific requirements of the single pending action to advance the company's patent objectives.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOESEN, CHRISTIAN C | 1 | 75.9% | +21.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918861 | VIRAL DELIVERY VEHICLE SELECTION | BOESEN, CHRISTIAN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918861 | VIRAL DELIVERY VEHICLE SELECTION | BOESEN, CHRISTIAN C | — |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17918861 | VIRAL DELIVERY VEHICLE SELECTION | BOESEN, CHRISTIAN C | 1684 | §101§102 | Non-Final OA | — | Pending | Oct 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial